Has the ASX 200 escaped a market correction?

The ASX 200 fell 9.43% from its record high last month to what may have been the trough last Thursday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) market sell-off appears to have stalled with a potential rebound now in effect.

As the chart below shows, ASX 200 shares have endured four consecutive weeks of falls.

The benchmark index fell 9.43% from its record high on 14 February to what may have been the trough last Thursday.

This left the ASX 200 teetering on the edge of an official market correction, which is defined as a 10% fall from the most recent peak.

But the benchmark index began lifting again last Friday, closing 0.52% higher at 7,789.7 points.

Yesterday, the ASX 200 closed up 1.02% at 7,854.10 points.

Today, the ASX 200 is currently just inside the green, up 0.014% to 7,855.2 points.

Time will tell if this is a permanent turnaround.

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.

Image source: Getty Images

What drove the market sell-off?

The biggest contributor to the market sell-off has been crumbling market sentiment as US President Donald Trump rolls out new tariffs.

The decision to impose tariffs goes against decades of trade cooperation between many Western nations.

We could well see a global trade war ensue, and that doesn't bode well for many businesses, not to mention the global economy.

The tariff disruption comes at a time when it appeared the global fight against COVID-driven inflation was largely over.

Last year, many countries, including the US, began cutting interest rates as inflation fell to acceptable levels.

Now there is concern that tariffs will eventually flow through to US consumer prices and reignite inflation in the world's largest economy.

All of this has made investors nervous, leading to falling confidence and a stock market sell-off in the US, with the ASX 200 following suit.

Last week, US President Donald Trump admitted there could be a "period of transition" as he imposes tariffs on many trading partners.

Trump said this in response to a TV journalist who asked him whether he expected a US recession this year.

The US stock market officially entered a market correction last week.

Analysts have been quick to reassure ASX 200 shares investors that market corrections are a normal part of the cycle.

Remember, this short, sharp correction occurred after the US and Australian share markets reached all-time record highs last month.

It's not uncommon to see markets cool off a bit after strong bull runs.

On top of that, nothing tangible has happened to justify this sell-off. It's largely the result of falling market sentiment.

Markets are fearful of what may happen as a result of tariffs. They are not reacting to any hard evidence of a negative impact.

Trump's unpredictable nature is also creating uncertainty, and markets do not cope well with uncertainty.

Until he's made all the decisions he's going to make on tariffs, the markets are in 'wait and see' mode.

That means markets are nervous, and that means volatility for stocks.

AMP chief economist, Dr Shane Oliver, said:

The main threat to Australia comes from Trump's trade war leading to a hit to global trade and growth leading to less demand for our exports. And this is largely why our share market has had a similar sized fall to the US share market.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A woman holds a soldering tool as she sits in front of a computer screen while working on the manufacturing of technology equipment in a laboratory environment.
Broker Notes

Netwealth shares could be set to rise 60% in the next 12 months – Expert

This could be a value play after key acquisition.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

Will the market rebound from yesterday's weakness? Let's find out.

Read more »

I young woman takes a bite out of a burrito n the street outside a Mexican fast-food establishment.
Broker Notes

Up 67%! Is it too late to buy the rally in Guzman Y Gomez shares now?

A leading expert delivers his verdict on the surging Guzman Y Gomez share price.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Woolworths and CBA shares

A leading expert believes investors would do well to exit their Woolworths and CBA share holdings. But why?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
ASX Share Market News

Brokers tip these 3 ASX shares to climb between 50% and 122% in the next 12 months

These ASX shares look significantly undervalued.

Read more »

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were back to hitting the sell button this Tuesday.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Buy, hold, sell: Domino's Pizza, Telix Pharmaceuticals, Westfarmers shares

Brokers have given their verdicts on these ASX shares.

Read more »

A rocket blasts off into space with planet behind it.
Opinions

SpaceX shares are flying. Here's the price I'd wait for

SpaceX is on my watchlist, but I’m staying patient.

Read more »